An in vitro retinoblastoma human triple culture model of angiogenesis: A modulatory effect of TGF-β

Cancer Letters

Volumn 354, Issue 1, 2014, Pages 181-188

  Lupo, Gabriella ^a   Motta, Carla ^a   Salmeri, Mario ^a   Spina Purrello, Vittoria ^a   Alberghina, Mario ^a   Anfuso, Carmelina Daniela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cytosolic and calcium independent PLA2; Human retinal microvascular endothelial cells; Human retinal microvascular pericytes; Retinoblastoma; TGF

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; PHOSPHOLIPASE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; PHOSPHOLIPASE A2;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULATURE; MOLECULAR MECHANICS; NEUROMODULATION; PERICYTE; PROTEIN EXPRESSION; RETINA CELL; RETINOBLASTOMA; CYTOLOGY; CYTOSOL; CYTOSOLIC AND CALCIUM-INDEPENDENT PLA(2); ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELLS; HUMAN RETINAL MICROVASCULAR PERICYTES; METABOLISM; MICROCIRCULATION; NEOVASCULARIZATION (PATHOLOGY); PERMEABILITY; RETINA; SIGNAL TRANSDUCTION; TGF-Β; TUMOR CELL CULTURE;

CYTOSOLIC AND CALCIUM-INDEPENDENT PLA(2); HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELLS; HUMAN RETINAL MICROVASCULAR PERICYTES; RETINOBLASTOMA; TGF-Β;

CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOSOL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PERMEABILITY; PHOSPHOLIPASES; PHOSPHOLIPASES A2; RETINA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84910022160     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.08.004     Document Type: Article

References (60)

1. Marback E.F., Arias V.E., Paranhos A., Soares F.A., Murphree A.L., Erwenne C.M. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br. J. Ophthalmol 2003, 87:1224-1228.
2. Broaddus E., Topham A., Singh A.D. Incidence of retinoblastoma in the USA: 1975-2004. Br. J. Ophthalmol 2009, 93:21-23.
3. Bulnes S., Bengoetxea H., Ortuzar N., Argandoña E.G., Garcia-Blanco A., Rico-Barrio I., et al. Angiogenic signalling pathways altered in gliomas: selection mechanisms for more aggressive neoplastic subpopulations with invasive phenotype. J. Signal Transduct 2012, 2012:597915.
4. Apte R.S., Harbour J.W. Inhibiting angiogenesis in retinoblastoma. Ophthalmic Res 2007, 39:188-190.
5. Winkler E.A., Bell R.D., Zlokovic B.V. Central nervous system pericytes in health and disease. Nat. Neurosci 2011, 14:1398-1405.
6. Pfister F., Przybyt E., Harmsen M.C., Hammes H.P. Pericytes in the eye. Pflugers Arch 2013, 465:789-796.
7. Tate M.C., Aghi M.K. Biology of angiogenesis and invasion in glioma. Neurother 2009, 6:447-457.
8. Machein M.R., Plate K.H. Role of VEGF in developmental angiogenesis and in tumor angiogenesis in the brain. Cancer Treat. Res 2004, 117:191-218.
9. Keeley E.C., Mehrad B., Strieter R.M. Chemokines as mediators of tumor angiogenesis and neovascularization. Exp. Cell Res 2011, 317:685-690.
10. Morikawa S., Ezaki T. Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol. Histopathol 2011, 26:979-995.
11. Principe D.R., Doll J.A., Bauer J., Jung B., Munshi H.G., Bartholin L., et al. TGF-β: duality of function between tumor prevention and carcinogenesis. J. Natl Cancer Inst 2014, 106:djt369.
12. Lebrin F., Deckers M., Bertolino P., ten Dijke P. TGF-β receptor function in the endothelium. Cardiovasc. Res 2005, 65:599-608.
13. Medici D., Potenta S., Kalluri R. Transforming growth factor-β2 promotes snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J. 2011, 437:515-520.
14. Walshe T.E., Saint-Geniez M., Maharaj A.S., Sekiyama E., Maldonado A.E., D'Amore P.A. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE 2009, 4:e5149.
15. Goumans M.J., Lebrin F., Valdimarsdottir G. Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovasc. Med 2003, 13:301-307.
16. Roberts A.B., Wakefield L.M. The two faces of transforming growth factor β in carcinogenesis. Proc. Natl Acad. Sci. U.S.A. 2003, 100:8621-8623.
17. Kajdaniuk D., Marek B., Foltyn W., Kos-Kudła B. Vascular endothelial growth factor (VEGF) -part 1: in physiology and pathophysiology. Endokrynol. Pol 2011, 62:444-455.
18. Subramanian J., Morgensztern D., Govindan R. Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin. Lung Cancer 2010, 11:311-319.
19. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
20. Choi Y.K., Kim J.H., Kim W.J., Lee H.Y., Park J.A., Lee S.-W., et al. AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J. Neurosci 2007, 27:4472-4481.
21. Anfuso C.D., Motta C., Giurdanella G., Arena V., Alberghina M., Lupo G. Endothelial PKCα-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes?. Biochimie 2014, 99:77-87.
22. Linkous A.G., Yazlovitskaya E.M., Hallahan D.E. Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J. Natl Cancer Inst 2010, 102:1398-1412.
23. Wendum D., Comperat E., Boëlle P.Y., Parc R., Masliah J., Trugnan G., et al. Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod. Pathol 2005, 18:212-220.
24. Tosato G., Segarra M., Salvucci O. Cytosolic phospholipase A2{alpha} and cancer: a role in tumor angiogenesis. J. Natl Cancer Inst 2010, 102:1377-1379.
25. Dennis E.A., Cao J., Hsu Y.H., Magrioti V., Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev 2011, 111:6130-6185.
26. Lupo G., Nicotra A., Giurdanella G., Anfuso C.D., Romeo L., Biondi G., et al. Activation of phospholipase A2 and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells. Biochim. Biophys. Acta 2005, 1735:135-150.
27. Salmeri M., Motta C., Anfuso C.D., Amodeo A., Scalia M., Toscano M.A., et al. VEGF receptor-1 involvement in pericyte loss induced by Escherichia coli in an in vitro model of blood brain barrier. Cell. Microbiol 2013, 15:1367-1384.
28. Wei J., Wu A., Kong L.Y., Fuller G., Foky I., Melillo G., et al. Hypoxia potentiates glioma-mediated immunosuppression. PLoS ONE 2011, 6:e16195. http://www.ncbi.nlm.nih.gov/pubmed/21283755.
29. Wang D., Dubois R.N. Eicosanoids and cancer. Nat. Rev. Cancer 2010, 10:181-193.
30. Singh-Ranger G., Salhab M., Mokbel K. The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res. Treat 2008, 109:189-198.
31. Kim J.H., Yu Y.S. Incidence (1991~1993) and survival rates (1991~2003) of retinoblastoma in Korea. J. Korean Ophthalmol. Soc 2010, 51:542-551.
32. Jockovich M.E., Piña Y., Alegret A., Cebulla C., Feuer W., Murray T.G. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy. Retina 2008, 28:S81-S86.
33. Areán C., Orellana M.E., Abourbih D., Abreu C., Pifano I., Burnier M.N. Expression of vascular endothelial growth factor in retinoblastoma. Arch. Ophthalmol 2010, 128:223-229.
34. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res 2005, 97(6):512-523.
35. Cooke V.G., LeBleu V.S., Keskin D., Khan Z., O'Connell J.T., Teng Y., et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012, 21(1):66-81.
36. Xian X., Håkansson J., Ståhlberg A., Lindblom P., Betsholtz C., Gerhardt H., et al. Pericytes limit tumor cell metastasis. J. Clin. Invest 2006, 116(3):642-651.
37. Ten Dijke P., Arthur H.M. Extracellular control of TGF-beta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol 2007, 8:857-869.
38. Murphy-Ullrich J.E., Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000, 11:59-69.
39. Larsson J., Goumans M.J., Sjostrand L.J., van Rooijen M.A., Ward D., Léeven P., et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 2001, 20:1663-1673.
40. Benson J.R. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol 2004, 5:229-239.
41. Wang J., Zhao J., Chu E.S., Mok M.T., Go M.Y., Man K., et al. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. J. Pathol 2013, 230:441-452.
42. Darland D.C., Massingham L.J., Smith S.R., Piek E., Saint-Geniez M., D'Amore P.A. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. Biol 2003, 264:275-288.
43. Xue K., Qian J., Bi Y.W., Yao Y.Q., Yuan Y.F., DA C.D. Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive. Zhonghua Yan Ke Za Zhi 2011, 47:134-141.
44. Lee S.Y., Kim D.K., Cho J.H., Koh J.Y., Yoon Y.H. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma. Arch. Ophthalmol 2008, 126:953-958.
45. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci 2008, b121:2115-2122.
46. Barnett J.M., McCollum G.W., Penn J.S. Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest. Ophthalmol. Vis. Sci 2010, 51:1136-1142.
47. Hatazawa R., Tanigami M., Izumi N., Kamei K., Tanaka A., Takeuchi K. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 2007, 15:214-217.
48. Ju W.K., Kim K.Y., Neufeld A.H. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp. Eye Res 2003, 77:137-145.
49. Rao R., Redha R., Macias-Perez I., Su Y., Hao C., Zent R., et al. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem 2007, 282:16959-16968.
50. Pai R., Szabo I.L., Soreghan B.A., Atay S., Kawanaka H., Tarnawski A.S. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem. Biophys. Res. Commun 2001, 286(5):923-928.
51. Holderfield M.T., Hughes C.C.W. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res 2008, 102:638-652.
52. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
53. Pardali E., ten Dijke P. Transforming growth factor-beta signaling and tumor angiogenesis. Front. Biosci. (Landmark Ed) 2009, 14:4848-4861.
54. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., et al. Activin receptor-like kinase 1 modulates TGF-β1 signaling in the regulation of angiogenesis. Proc. Natl Acad. Sci. U.S.A. 2000, 97:2626-2631.
55. Wu X., Ma J., Han J.D., Wang N., Chen Y.G. Distinct regulation of gene expression in human endothelial cells by TGF-β and its receptors. Microvasc. Res 2006, 71:12-19.
56. Loureiro R.M., D'Amore P.A. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005, 16:77-89.
57. Geng L., Chaudhuri A., Talmon G., Wisecarver J.L., Wang J. TGF-beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis. PLoS ONE 2013, 8(3):e59918.
58. Ferrari G., Terushkin V., Wolff M.J., Zhang X., Valacca C., Poggio P., et al. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38 MAPK from the prosurvival p38β to proapoptotic p38α. Mol. Cancer Res 2012, 10:605-614.
59. Han C., Bowen W.C., Li G., Demetris A.J., Michalopoulos G.K., Wu T. Cytosolic phospholipase A2α and peroxisome proliferator-activated receptor γ signaling pathway counteracts transforming growth factor β-mediated inhibition of primary and transformed hepatocyte growth. Hepatology 2010, 52:644-655.
60. Matsumura T., Suzuki T., Aizawa K., Sawaki D., Munemasa Y., Ishida J., et al. Regulation of transforming growth factor-β-dependent cyclooxygenase-2 expression in fibroblasts. J. Biol. Chem 2009, 284:35861-35871.